Vivacelle Bio Commemorates Sepsis Awareness Month in U.S. Hospitals
24 Sep 2024 //
PR NEWSWIRE
Vivacelle Bio’s VBI-S PhIIa Trial Meets Primary and Secondary Endpoints
09 Feb 2023 //
BUSINESSWIRE
Vivacelle Bio Announces Results of Phase IIa Trial of VBI-S
20 Oct 2022 //
BUSINESSWIRE

Market Place
Sourcing Support